Clinical Trial Update: Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial of Bryostatin-1 in relapsed non-Hodgkin lymphoma or chronic lymphocytic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• Bryostatin-1 (bryostatin-1)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED